Literature DB >> 20593667

[Wernicke encephalopathy in a non-alcoholic patient with diabetic nephropathy under hemodialysis].

Setsu Nakatani-Enomoto1, Arata Moriya, Saeko Kikuchi, Hitoshi Mochizuki, Yoshihiro Sugiura, Yoshikazu Ugawa.   

Abstract

A 75-year-old man with diabetic nephropathy treated with hemodialysis visited to a medical office because of slight fever, and received intravenous glucose infusion without any vitamins. Thereafter, he noticed gait disturbance and began to tell inconsistent stories. He was admitted to our hospital due to aggravation of these symptoms. On admission, he was disoriented and not able to sit by himself because of severe truncal ataxia without weakness. He had also gaze direction nystagmus. Based on clinical features, we considered him as having Wernicke's encephalopathy (WE) and treated him with 100 mg thiamine per day. The thiamine supply diminished these symptoms soon. Plasma thiamine level prior to the administration was 7 ng/ml, which confirmed the diagnosis. MRI did not disclose any abnormalities frequently seen in WE. WE is a life-threatening disease, and 'early detection, early cure' is important for recovering without sequelae. The thiamine deficiency is often seen in dialysis patients because of dietary restrictions as well as its loss during dialysis. This case gives us the caution; when hemodialysis patients present acute/subacute gait disturbance and/ or abnormal mental state, we should consider WE. Furthermore, high-risk patients, such as elderly patients under hemodialysis may need some supplement including thiamine even at preclinical stage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593667     DOI: 10.5692/clinicalneurol.50.409

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  A case of Wernicke encephalopathy arising in the early stage after the start of hemodialysis.

Authors:  Nayuta Seto; Mayumi Ishida; Tatsuya Hamano; Hideki Onishi; Nozomu Uchida
Journal:  CEN Case Rep       Date:  2022-01-06

Review 2.  Wernicke's encephalopathy: expanding the diagnostic toolbox.

Authors:  Mary E Lough
Journal:  Neuropsychol Rev       Date:  2012-05-11       Impact factor: 7.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.